MoonLake Immunotherapeutics

MLTX Healthcare Biotechnology

In the quarter to June 2026, EPS grew 3.45%, free cash flow fell 1.89% and total debt rose 35.6%, each against the same quarter a year earlier.

9.55 0.71 −6.92%
Market cap
$873.2M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Total current assets
570.04 396.64 421.69 411.22
Total non-current assets
3.91 3.73 2.74 3.12
Total Assets
573.95 400.37 424.43 414.34
Total current liabilities
45.39 46.11 45.48 48.37
Total non-current liabilities
100.36 100.24 74.47 74.78
Total liabilities
145.75 146.35 119.95 123.14
Common Equity (Total)
428.20 254.02 304.48 291.19
Shareholders Equity (Total)
428.20 254.02 304.48 291.19
Total Debt
99.51 99.02 74.10 73.74

Show all line items

In millions of $ except per-share values · columns are period end dates